Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Medical Solutions Group Plc LSE:AMS London Ordinary Share GB0004536594 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  8.00 3.29% 251.00 152,620 15:04:47
Bid Price Offer Price High Price Low Price Open Price
249.00 251.00 251.00 240.50 240.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 102.37 24.26 8.81 28.5 540
Last Trade Time Trade Type Trade Size Trade Price Currency
15:06:36 O 3 249.04 GBX

Advanced Medical Solutions (AMS) Latest News

More Advanced Medical Solutions News
Advanced Medical Solutions Investors    Advanced Medical Solutions Takeover Rumours

Advanced Medical Solutions (AMS) Discussions and Chat

Advanced Medical Solutions Forums and Chat

Date Time Title Posts
24/11/202007:52Advanced Medical Solutions (AMS)3,206
19/10/201207:53AMS (Advanced Medical Systems). The next BULL stock.3,430
20/2/200909:39STRONG BUY !!!!!! ADVANCED MEDICAL412
20/2/200909:35Got wood?190
20/2/200909:33AMS ..Undervalued????????6

Add a New Thread

Advanced Medical Solutions (AMS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Advanced Medical Solutions trades in real-time

Advanced Medical Solutions (AMS) Top Chat Posts

Advanced Medical Solutions Daily Update: Advanced Medical Solutions Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker AMS. The last closing price for Advanced Medical Solutions was 243p.
Advanced Medical Solutions Group Plc has a 4 week average price of 194p and a 12 week average price of 194p.
The 1 year high share price is 312p while the 1 year low share price is currently 190p.
There are currently 215,277,568 shares in issue and the average daily traded volume is 599,046 shares. The market capitalisation of Advanced Medical Solutions Group Plc is £540,346,695.68.
wetdream: Looks like the news caused some trading algorithms to go into meltdown! Dozens of single share trades before 8.30am. Weird.
energeticbacker: Advanced Medical Solutions acquires Raleigh Adhesive Coatings, reports Investor's Champion. For the 6 months ending 31 October Raleigh generated revenue of £3.9m and operating profit of £0.8m, compared to the prior year’s loss of £0.3m. The £22m acquisition cost therefore represents quite a multiple, suggesting AMS thinks highly of this business.
energeticbacker: AMS received CE mark approval for its Silicone PHMB Foam Dressing, which sits alongside the previously US approval for this product. AMS has had a tough time over the pandemic which has led to the deferral of elective surgeries and woundcare clinics, however, according to Investor's Champion this innovative business remains in good shape and should continue to thrive when markets recover.
winnings1: Alliance Pharma (APH) looks even better value. Medicines will not go out of fashion and are unlikely to suffer long term economic disruption from Covid-19. Chairman and wife bought substantial amountsAPH shares at 77.7p in June, the shares were cheap enough then, even cheaper now at around 70p! AMS'downward trend may have a bit further to go. A sound Company with loads of cash in the bank. Share price Will come up again, depending on next Results showing improved sales.
dealit: Let us hope this announcement as a positive effect on the s/p:- Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, today announces that it has been granted UK and US patents for the LiquiBand® Exceed range, providing protection until 2034. The design of the applicator, tip and the raw materials used to manufacture the device has allowed it to be distinguished as a novel, patentable technology. These patents provide long-term protection on a core growth driver for the global LiquiBand® portfolio, covering 30-35% of the current product range. In addition, the UK patent will provide an additional tax benefit to the Group via the UK patent box scheme that is expected to reduce the effective tax rate for the Group by between 1% and 2% throughout the patent life. Chris Meredith, Chief Executive Officer of AMS, commented: "With end sales demand for LiquiBand® in the US showing early signs of recovery demonstrated by market share gains in the first quarter of 2020, these newly granted patents will further strengthen and protect growth in our core markets. They also highlight AMS's continued ability to design, develop and sell innovative, patentable technology."
wetdream: AMS - the share the market forgot. How restful it must be, knowing that NOONE is talking about you. Zzzzzz
willir20: AMS chart has been interesting over the last few weeks, with the share price climbing back above the 25 day and 50 day moving averages in November and then, importantly, above the 200 day moving average on December 18th--to remain north of that line since that date. The share price is only a short step away from 300p, so any New Year rally may take us over the line (though perhaps to trigger some short term profit taking). AMS is a well managed company and the recent acquisitions (bought from cash in hand) should add to status, breadth of offerings and earnings. Let's hope we get back on track in 2020 and test 400p by next Christmas. GLA.
willir20: Hi Dealit: FDA approval for two new AMS wound care products--which testify to the company's continuing desire to innovate and grow revenues organically--was announced, as you point out, on July 30th. I agree that it is disappointing and somewhat puzzling that the share price did not turn sharply upwards at this very welcome development, though I wonder whether it may have taken a day or so for investors to catch up with the news. If you look at the trajectory of the share price from July 31st to today, it is easy to spot a clear, albeit modest, upward trend (delineated by higher highs and higher lows). Just where this upswing will end is a matter of guesswork in a market that is so badly depressed by global events that have most investors rattled. In my view, AMS is a world class company, whose success in the future promises to be every bit as exciting as it has been over past years. It fits Jim Slater's celebrated Zulu principle perfectly. I still hold all of the shares I bought years ago (for an average in single digits) and, as long as the stellar performance is repeated, year in, year out, I cannot imagine wanting to sell them. A take over would obviously force my hand but I would strongly resist surrendering my holding at less than £5.00 a share.
dealit: Why does AMS share price move up and down on such small volume?
dealit: Strange sort of day for AMS share price up 6% at one stage and finishes the day up just 1% on very small volume, are MM`s playing games.
Advanced Medical Solutions share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Advanced M..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201126 15:22:43